David R. Peaper

7.6k total citations · 2 hit papers
74 papers, 4.7k citations indexed

About

David R. Peaper is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, David R. Peaper has authored 74 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Infectious Diseases, 23 papers in Epidemiology and 17 papers in Clinical Biochemistry. Recurrent topics in David R. Peaper's work include Bacterial Identification and Susceptibility Testing (17 papers), SARS-CoV-2 detection and testing (11 papers) and SARS-CoV-2 and COVID-19 Research (8 papers). David R. Peaper is often cited by papers focused on Bacterial Identification and Susceptibility Testing (17 papers), SARS-CoV-2 detection and testing (11 papers) and SARS-CoV-2 and COVID-19 Research (8 papers). David R. Peaper collaborates with scholars based in United States, Saudi Arabia and France. David R. Peaper's co-authors include Peter Cresswell, Thomas S. Murray, Pamela A. Wearsch, Akiko Iwasaki, Yosuke Kumamoto, Takeshi Ichinohe, Iris K. Pang, John Ho, Jorge Henao‐Mejia and Carmen J. Booth and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

David R. Peaper

70 papers receiving 4.6k citations

Hit Papers

NLRP6 Inflammasome Regulates Colonic Microbial Ecology an... 2011 2026 2016 2021 2011 2011 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David R. Peaper United States 23 2.6k 1.7k 1.2k 870 352 74 4.7k
Daisuke Motooka Japan 38 2.7k 1.0× 904 0.5× 1.0k 0.9× 912 1.0× 489 1.4× 270 5.7k
Cristina Cunha Portugal 30 1.8k 0.7× 1.4k 0.8× 1.9k 1.6× 1.5k 1.7× 310 0.9× 91 4.9k
Cui Hua Liu China 34 3.0k 1.2× 1.2k 0.7× 1.8k 1.5× 1.2k 1.4× 344 1.0× 72 5.2k
Eva Medina Germany 44 2.0k 0.8× 2.7k 1.6× 2.1k 1.8× 1.1k 1.3× 407 1.2× 128 6.6k
Teruo Kirikae Japan 37 1.5k 0.6× 1.1k 0.7× 1.3k 1.1× 807 0.9× 308 0.9× 191 4.3k
David H. Dockrell United Kingdom 50 2.0k 0.8× 2.6k 1.6× 1.2k 1.0× 2.2k 2.6× 260 0.7× 143 7.3k
Viviane Balloy France 40 1.4k 0.5× 2.1k 1.2× 1.2k 1.0× 1.2k 1.4× 202 0.6× 79 5.1k
Yun‐Gi Kim Japan 34 3.7k 1.4× 3.4k 2.0× 1.2k 1.0× 1.3k 1.5× 717 2.0× 73 7.3k
Bhanu Sinha Netherlands 43 2.4k 0.9× 950 0.6× 2.4k 2.0× 1.3k 1.5× 305 0.9× 135 6.0k
Costi D. Sifri United States 39 1.9k 0.7× 501 0.3× 1.4k 1.2× 992 1.1× 373 1.1× 118 5.3k

Countries citing papers authored by David R. Peaper

Since Specialization
Citations

This map shows the geographic impact of David R. Peaper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Peaper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Peaper more than expected).

Fields of papers citing papers by David R. Peaper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Peaper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Peaper. The network helps show where David R. Peaper may publish in the future.

Co-authorship network of co-authors of David R. Peaper

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Peaper. A scholar is included among the top collaborators of David R. Peaper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Peaper. David R. Peaper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dudgeon, Sarah, Nagarjuna R. Cheemarla, H. P. Young, et al.. (2025). Nasal biomarker testing to rule out viral respiratory infection and triage samples: a test performance study. EBioMedicine. 117. 105820–105820.
2.
Luhung, Irvan, Hannah Greenwald, Scott C. Roberts, et al.. (2025). Aerosol-based exposure to opportunistic pathogens originating from hospital sink drains. American Journal of Infection Control. 54(3). 275–281. 1 indexed citations
3.
Peaper, David R., Christopher D. Doern, & Susan E. Sharp. (2024). Proceedings of the Clinical Microbiology Open 2022—assessing clinical laboratory and industry responses to COVID-19 pandemic testing capacity challenges (part 1). Journal of Clinical Microbiology. 62(3). e0094123–e0094123.
4.
Loza, Andrew J., et al.. (2023). PROSER: A Web-Based Peripheral Blood Smear Interpretation Support Tool Utilizing Electronic Health Record Data. American Journal of Clinical Pathology. 160(1). 98–105. 1 indexed citations
5.
Khera, Rohan, Bobak J. Mortazavi, Veer Sangha, et al.. (2022). A multicenter evaluation of computable phenotyping approaches for SARS-CoV-2 infection and COVID-19 hospitalizations. npj Digital Medicine. 5(1). 27–27. 8 indexed citations
6.
Peaper, David R., Daniel D. Rhoads, Kaede V. Sullivan, et al.. (2021). Considerations from the College of American Pathologists for Implementation of an Assay for SARS-CoV-2 Testing after a Change in Regulatory Status. Journal of Clinical Microbiology. 59(10). e0116721–e0116721. 6 indexed citations
7.
Roberts, Scott C., David R. Peaper, L. Scott Sussman, Richard A. Martinello, & Christian M. Pettker. (2021). Utility of Mass SARS-CoV-2 Testing of Asymptomatic Patients Before Ambulatory and Inpatient Preplanned Procedures Requiring Moderate Sedation or General Anesthesia. JAMA Network Open. 4(6). e2114526–e2114526. 1 indexed citations
8.
Roberts, Scott C., David R. Peaper, L. Scott Sussman, et al.. (2021). Mass severe acute respiratory coronavirus 2 (SARS-CoV-2) testing of asymptomatic healthcare personnel. Infection Control and Hospital Epidemiology. 42(5). 625–626. 6 indexed citations
9.
Peaper, David R., Vivek Parwani, Andrew Ulrich, et al.. (2020). Clinical impact of rapid influenza PCR in the adult emergency department on patient management, ED length of stay, and nosocomial infection rate. Influenza and Other Respiratory Viruses. 15(2). 254–261. 11 indexed citations
10.
Landry, Marie L., et al.. (2020). Challenges in use of saliva for detection of SARS CoV-2 RNA in symptomatic outpatients. Journal of Clinical Virology. 130. 104567–104567. 103 indexed citations
11.
Gaston, David C., Maricar Malinis, David R. Peaper, et al.. (2020). Clinical implications of SARS-CoV-2 cycle threshold values in solid organ transplant recipients. American Journal of Transplantation. 21(3). 1304–1311. 16 indexed citations
12.
Gabryszewski, Stanislaw J., Tania Wong Fok Lung, Medini K. Annavajhala, et al.. (2019). Metabolic Adaptation in Methicillin-Resistant Staphylococcus aureus Pneumonia. American Journal of Respiratory Cell and Molecular Biology. 61(2). 185–197. 39 indexed citations
13.
Sudikoff, Stephanie N., et al.. (2019). The effectiveness of a novel colorant additive in the daily cleaning of patient rooms. Infection Control and Hospital Epidemiology. 40(6). 721–723. 4 indexed citations
14.
Lau, K. H. Vincent, et al.. (2016). Meningitis Caused by Candida Dubliniensis in a Patient with Cirrhosis: A Case Report and Review of the Literature. Mycopathologia. 181(7-8). 589–593. 20 indexed citations
15.
Sack, Jordan, David R. Peaper, Pramod K. Mistry, & Maricar Malinis. (2016). Clinical implications of Paracoccus yeeii bacteremia in a patient with decompensated cirrhosis. IDCases. 7. 9–10. 6 indexed citations
16.
Elinav, Eran, Till Strowig, Andrew L. Kau, et al.. (2011). NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis. Cell. 145(5). 745–757. 1572 indexed citations breakdown →
17.
Vigneron, Nathalie, David R. Peaper, Ralf M. Leonhardt, & Peter Cresswell. (2009). Functional significance of tapasin membrane association and disulfide linkage to ERp57 in MHC class I presentation. European Journal of Immunology. 39(9). 2371–2376. 23 indexed citations
18.
Dong, Gang, Pamela A. Wearsch, David R. Peaper, Peter Cresswell, & Karin M. Reinisch. (2009). Insights into MHC Class I Peptide Loading from the Structure of the Tapasin-ERp57 Thiol Oxidoreductase Heterodimer. Immunity. 30(1). 21–32. 232 indexed citations
19.
Peaper, David R., Pamela A. Wearsch, & Peter Cresswell. (2005). Tapasin and ERp57 form a stable disulfide‐linked dimer within the MHC class I peptide‐loading complex. The EMBO Journal. 24(20). 3613–3623. 143 indexed citations
20.
Cresswell, Peter, Anne L. Ackerman, Alessandra Giodini, David R. Peaper, & Pamela A. Wearsch. (2005). Mechanisms of MHC class I‐restricted antigen processing and cross‐presentation. Immunological Reviews. 207(1). 145–157. 326 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026